Article
NOD2 variants and the risk of malignant melanoma.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) - 1 Apr 2005
Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Debniak B, Rozmiarek A, Dziuba I, Złowocka E, Suchy J, Górski B, Cybulski C, Mierzejewski M, Masojć B, Medrek K, Oszurek O, Lubiński J
Abstract excerpt
Both hereditary and environmental factors are important in the aetiology of malignant melanoma. Among the risk factors for malignant melanoma are immunodeficiency and immunosuppression. The recently identified NOD2 gene is involved in the regulation of immune function through activation of the transcription factor nuclear factor-kappaB (NF-kappaB). Three common NOD2 mutations -- 3020insC, G908R and R702W -- have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
